Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mersina in Type 2 Diabetes with Secondary Failure
NCT00940251Phase 2Completed
- Sponsor
- Jyoti Clinical and Pathological Laboratory
- Start
- Sep 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mersina in type 2 diabetes mellitus (T2DM), sponsored by Jyoti Clinical and Pathological Laboratory. Started Sep 2008; status: completed.
02
Drugs
Mersina
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00940251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940251.